Boosting antibody responses to Plasmodium falciparum merozoite antigens in children with highly seasonal exposure to infection.
Longitudinal cohort studies are important to describe the dynamics of naturally acquired antibody response profiles to defined Plasmodium falciparum malaria antigens relative to clinical malaria episodes. In children under 7 years of age in The Gambia, serum IgG responses were measured to P. falciparum merozoite antigens AMA1, EBA175, MSP1(19), MSP2 and crude schizont extract, over a 10-month period. Persistence of antibody responses was measured in 152 children during the dry season when there was virtually no malaria transmission, and 103 children were monitored for new episodes of clinical malaria during the subsequent wet season when transmission occurred. Children who experienced clinical malaria had lower antibody levels at the start of the study than those who remained free from malaria. Associations between dry season antibody persistence and subsequent wet season antibody levels suggested robust immunological memory responses. Mean antibody levels to all antigens were elevated by the end of the wet season in children who experienced clinical malaria; each of these children had a boosted antibody response to at least one antigen. In all children, antibody avidities were lower against MSP2 than other antigens, a difference that did not change throughout the study period or in relation to clinical malaria episodes.
Akpogheneta
O J
OJ
Medical Research Council Laboratories, Fajara, The Gambia. o.akpogheneta@yahoo.com
Dunyo
S
S
Pinder
M
M
Conway
D J
DJ
D000818:Animals; D000913:Antibodies, Protozoan / Q000097:blood*; D000953:Antigens, Protozoan / Q000276:immunology*; D002648:Child; D002675:Child, Preschool; D015331:Cohort Studies; D005260:Female; D005714:Gambia; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood; D007223:Infant; D007231:Infant, Newborn; D008137:Longitudinal Studies; D016778:Malaria, Falciparum / Q000276:immunology* / Q000473:pathology; D008297:Male; D052940:Merozoites / Q000276:immunology*; D010963:Plasmodium falciparum / Q000276:immunology*; D012621:Seasons
D000913:Antibodies, Protozoan; D000953:Antigens, Protozoan; D007074:Immunoglobulin G
J Immunol. 1998 Jul 1;161(1):347-59
9647243
Ann Trop Med Parasitol. 2005 Sep;99(6):553-62
16156968
Parasite Immunol. 1992 May;14(3):321-37
1625908
Am J Trop Med Hyg. 1996 May;54(5):443-8
8644896
Mol Biochem Parasitol. 1994 Mar;64(1):165-9
8078519
Parasite Immunol. 1986 Nov;8(6):529-39
3543808
Lancet. 2008 Nov 1;372(9649):1545-54
18984187
Infect Immun. 2008 Sep;76(9):3924-31
18559428
Clin Vaccine Immunol. 2009 Mar;16(3):293-302
19116303
Vaccine. 2004 Dec 16;23(5):718-28
15542195
Malar J. 2008 Sep 24;7:186
18816374
Immunol Lett. 2000 Feb 1;71(2):117-26
10714439
Infect Immun. 1995 Nov;63(11):4382-8
7591074
Parasite Immunol. 2007 Sep;29(9):435-44
17727567
Infect Immun. 2002 Jun;70(6):3101-10
12011004
Infect Immun. 2008 Apr;76(4):1748-55
18212081
Infect Immun. 2004 Jan;72(1):584-8
14688140
Infect Immun. 1997 Sep;65(9):3631-7
9284129
J Acquir Immune Defic Syndr. 2003 Apr 1;32(4):424-8
12640201
Clin Diagn Lab Immunol. 2001 Sep;8(5):904-8
11527801
J Infect Dis. 2003 Feb 15;187(4):667-74
12599084
Infect Immun. 2008 May;76(5):2240-8
18316390
Parasite Immunol. 2003 Jun;25(6):307-12
14507328
Infect Immun. 2002 Jun;70(6):2982-8
12010988
Infect Immun. 2005 Jan;73(1):369-77
15618174
Am J Trop Med Hyg. 1996 Sep;55(3):315-23
8842122
Parasite Immunol. 1996 Aug;18(8):411-20
9229395
Vaccine. 2006 May 8;24(19):4233-46
16111789